Medically refractory gastroesophageal reflux disease in the obese: what is the best surgical approach?
Background Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be appropriate in the morbidly obese, especially when other effective alternatives exist (bariatric surgery). Methods A 13-item survey was designed to el...
Saved in:
Published in | Surgical endoscopy Vol. 28; no. 5; pp. 1500 - 1504 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Boston
Springer US
01.05.2014
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0930-2794 1432-2218 1432-2218 |
DOI | 10.1007/s00464-013-3343-3 |
Cover
Abstract | Background
Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be appropriate in the morbidly obese, especially when other effective alternatives exist (bariatric surgery).
Methods
A 13-item survey was designed to elicit professional opinions regarding the treatment of medically refractory GERD in obese patients. Members of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) were randomly selected and emailed a link to an online survey.
Results
A total of 550 surgeons were contacted via email, and 92 (17 %) completed the survey. Of the respondents, 88 % perform laparoscopic antireflux surgery, 63 % perform bariatric surgery, and 59 % perform both. Overall, 77 % completed a minimally invasive surgery fellowship. In response to the question “Would you perform a laparoscopic fundoplication in a patient with medically refractory GERD and a BMI of ‘X’?” surgeons were less likely to offer fundoplication at a higher body mass index (BMI). The majority of respondents felt that laparoscopic Roux-en-Y gastric bypass was the best option (91 %), followed by laparoscopic sleeve gastrectomy (6 %). Many had a morbidly obese patient with a primary surgical indication of GERD denied a bariatric procedure by their insurance company (57 %), and 35 % of those surgeons chose to do nothing rather than subject the patient to a fundoplication. Respondents uniformly felt that bariatric surgery should be recognized as a standard surgical option for treating GERD in the obese (96 %).
Conclusion
When surgical treatment of GERD is indicated in an obese patient, bariatric surgery is the optimal approach, in the opinion of surgeons responding to our survey. Unfortunately, third-party payers often decline to provide benefits for a bariatric procedure for this indication. Additional data is necessary to confirm our belief that the opinions elicited through this survey are consistent with the standard of care as defined by the medical community. |
---|---|
AbstractList | Background
Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be appropriate in the morbidly obese, especially when other effective alternatives exist (bariatric surgery).
Methods
A 13-item survey was designed to elicit professional opinions regarding the treatment of medically refractory GERD in obese patients. Members of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) were randomly selected and emailed a link to an online survey.
Results
A total of 550 surgeons were contacted via email, and 92 (17 %) completed the survey. Of the respondents, 88 % perform laparoscopic antireflux surgery, 63 % perform bariatric surgery, and 59 % perform both. Overall, 77 % completed a minimally invasive surgery fellowship. In response to the question “Would you perform a laparoscopic fundoplication in a patient with medically refractory GERD and a BMI of ‘X’?” surgeons were less likely to offer fundoplication at a higher body mass index (BMI). The majority of respondents felt that laparoscopic Roux-en-Y gastric bypass was the best option (91 %), followed by laparoscopic sleeve gastrectomy (6 %). Many had a morbidly obese patient with a primary surgical indication of GERD denied a bariatric procedure by their insurance company (57 %), and 35 % of those surgeons chose to do nothing rather than subject the patient to a fundoplication. Respondents uniformly felt that bariatric surgery should be recognized as a standard surgical option for treating GERD in the obese (96 %).
Conclusion
When surgical treatment of GERD is indicated in an obese patient, bariatric surgery is the optimal approach, in the opinion of surgeons responding to our survey. Unfortunately, third-party payers often decline to provide benefits for a bariatric procedure for this indication. Additional data is necessary to confirm our belief that the opinions elicited through this survey are consistent with the standard of care as defined by the medical community. Background: Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be appropriate in the morbidly obese, especially when other effective alternatives exist (bariatric surgery). Methods: A 13-item survey was designed to elicit professional opinions regarding the treatment of medically refractory GERD in obese patients. Members of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) were randomly selected and emailed a link to an online survey. Results: A total of 550 surgeons were contacted via email, and 92 (17 %) completed the survey. Of the respondents, 88 % perform laparoscopic antireflux surgery, 63 % perform bariatric surgery, and 59 % perform both. Overall, 77 % completed a minimally invasive surgery fellowship. In response to the question "Would you perform a laparoscopic fundoplication in a patient with medically refractory GERD and a BMI of 'X'?" surgeons were less likely to offer fundoplication at a higher body mass index (BMI). The majority of respondents felt that laparoscopic Roux-en-Y gastric bypass was the best option (91 %), followed by laparoscopic sleeve gastrectomy (6 %). Many had a morbidly obese patient with a primary surgical indication of GERD denied a bariatric procedure by their insurance company (57 %), and 35 % of those surgeons chose to do nothing rather than subject the patient to a fundoplication. Respondents uniformly felt that bariatric surgery should be recognized as a standard surgical option for treating GERD in the obese (96 %). Conclusion: When surgical treatment of GERD is indicated in an obese patient, bariatric surgery is the optimal approach, in the opinion of surgeons responding to our survey. Unfortunately, third-party payers often decline to provide benefits for a bariatric procedure for this indication. Additional data is necessary to confirm our belief that the opinions elicited through this survey are consistent with the standard of care as defined by the medical community. Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be appropriate in the morbidly obese, especially when other effective alternatives exist (bariatric surgery).BACKGROUNDObesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be appropriate in the morbidly obese, especially when other effective alternatives exist (bariatric surgery).A 13-item survey was designed to elicit professional opinions regarding the treatment of medically refractory GERD in obese patients. Members of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) were randomly selected and emailed a link to an online survey.METHODSA 13-item survey was designed to elicit professional opinions regarding the treatment of medically refractory GERD in obese patients. Members of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) were randomly selected and emailed a link to an online survey.A total of 550 surgeons were contacted via email, and 92 (17 %) completed the survey. Of the respondents, 88 % perform laparoscopic antireflux surgery, 63 % perform bariatric surgery, and 59 % perform both. Overall, 77 % completed a minimally invasive surgery fellowship. In response to the question "Would you perform a laparoscopic fundoplication in a patient with medically refractory GERD and a BMI of 'X'?" surgeons were less likely to offer fundoplication at a higher body mass index (BMI). The majority of respondents felt that laparoscopic Roux-en-Y gastric bypass was the best option (91 %), followed by laparoscopic sleeve gastrectomy (6 %). Many had a morbidly obese patient with a primary surgical indication of GERD denied a bariatric procedure by their insurance company (57 %), and 35 % of those surgeons chose to do nothing rather than subject the patient to a fundoplication. Respondents uniformly felt that bariatric surgery should be recognized as a standard surgical option for treating GERD in the obese (96 %).RESULTSA total of 550 surgeons were contacted via email, and 92 (17 %) completed the survey. Of the respondents, 88 % perform laparoscopic antireflux surgery, 63 % perform bariatric surgery, and 59 % perform both. Overall, 77 % completed a minimally invasive surgery fellowship. In response to the question "Would you perform a laparoscopic fundoplication in a patient with medically refractory GERD and a BMI of 'X'?" surgeons were less likely to offer fundoplication at a higher body mass index (BMI). The majority of respondents felt that laparoscopic Roux-en-Y gastric bypass was the best option (91 %), followed by laparoscopic sleeve gastrectomy (6 %). Many had a morbidly obese patient with a primary surgical indication of GERD denied a bariatric procedure by their insurance company (57 %), and 35 % of those surgeons chose to do nothing rather than subject the patient to a fundoplication. Respondents uniformly felt that bariatric surgery should be recognized as a standard surgical option for treating GERD in the obese (96 %).When surgical treatment of GERD is indicated in an obese patient, bariatric surgery is the optimal approach, in the opinion of surgeons responding to our survey. Unfortunately, third-party payers often decline to provide benefits for a bariatric procedure for this indication. Additional data is necessary to confirm our belief that the opinions elicited through this survey are consistent with the standard of care as defined by the medical community.CONCLUSIONWhen surgical treatment of GERD is indicated in an obese patient, bariatric surgery is the optimal approach, in the opinion of surgeons responding to our survey. Unfortunately, third-party payers often decline to provide benefits for a bariatric procedure for this indication. Additional data is necessary to confirm our belief that the opinions elicited through this survey are consistent with the standard of care as defined by the medical community. Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be appropriate in the morbidly obese, especially when other effective alternatives exist (bariatric surgery). A 13-item survey was designed to elicit professional opinions regarding the treatment of medically refractory GERD in obese patients. Members of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) were randomly selected and emailed a link to an online survey. A total of 550 surgeons were contacted via email, and 92 (17 %) completed the survey. Of the respondents, 88 % perform laparoscopic antireflux surgery, 63 % perform bariatric surgery, and 59 % perform both. Overall, 77 % completed a minimally invasive surgery fellowship. In response to the question "Would you perform a laparoscopic fundoplication in a patient with medically refractory GERD and a BMI of 'X'?" surgeons were less likely to offer fundoplication at a higher body mass index (BMI). The majority of respondents felt that laparoscopic Roux-en-Y gastric bypass was the best option (91 %), followed by laparoscopic sleeve gastrectomy (6 %). Many had a morbidly obese patient with a primary surgical indication of GERD denied a bariatric procedure by their insurance company (57 %), and 35 % of those surgeons chose to do nothing rather than subject the patient to a fundoplication. Respondents uniformly felt that bariatric surgery should be recognized as a standard surgical option for treating GERD in the obese (96 %). When surgical treatment of GERD is indicated in an obese patient, bariatric surgery is the optimal approach, in the opinion of surgeons responding to our survey. Unfortunately, third-party payers often decline to provide benefits for a bariatric procedure for this indication. Additional data is necessary to confirm our belief that the opinions elicited through this survey are consistent with the standard of care as defined by the medical community. Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be appropriate in the morbidly obese, especially when other effective alternatives exist (bariatric surgery). A 13-item survey was designed to elicit professional opinions regarding the treatment of medically refractory GERD in obese patients. Members of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) were randomly selected and emailed a link to an online survey. A total of 550 surgeons were contacted via email, and 92 (17 %) completed the survey. Of the respondents, 88 % perform laparoscopic antireflux surgery, 63 % perform bariatric surgery, and 59 % perform both. Overall, 77 % completed a minimally invasive surgery fellowship. In response to the question "Would you perform a laparoscopic fundoplication in a patient with medically refractory GERD and a BMI of 'X'?" surgeons were less likely to offer fundoplication at a higher body mass index (BMI). The majority of respondents felt that laparoscopic Roux-en-Y gastric bypass was the best option (91 %), followed by laparoscopic sleeve gastrectomy (6 %). Many had a morbidly obese patient with a primary surgical indication of GERD denied a bariatric procedure by their insurance company (57 %), and 35 % of those surgeons chose to do nothing rather than subject the patient to a fundoplication. Respondents uniformly felt that bariatric surgery should be recognized as a standard surgical option for treating GERD in the obese (96 %). When surgical treatment of GERD is indicated in an obese patient, bariatric surgery is the optimal approach, in the opinion of surgeons responding to our survey. Unfortunately, third-party payers often decline to provide benefits for a bariatric procedure for this indication. Additional data is necessary to confirm our belief that the opinions elicited through this survey are consistent with the standard of care as defined by the medical community.[PUBLICATION ABSTRACT] |
Author | Bosler, Matthew Pagé, Maurice-Pierre Goldblatt, Matthew Gould, Jon Kastenmeier, Andrew Wallace, James Frelich, Matthew |
Author_xml | – sequence: 1 givenname: Maurice-Pierre surname: Pagé fullname: Pagé, Maurice-Pierre organization: Department of Surgery, Division of General Surgery, Medical College of Wisconsin – sequence: 2 givenname: Andrew surname: Kastenmeier fullname: Kastenmeier, Andrew organization: Department of Surgery, Division of General Surgery, Medical College of Wisconsin – sequence: 3 givenname: Matthew surname: Goldblatt fullname: Goldblatt, Matthew organization: Department of Surgery, Division of General Surgery, Medical College of Wisconsin – sequence: 4 givenname: Matthew surname: Frelich fullname: Frelich, Matthew organization: Department of Surgery, Division of General Surgery, Medical College of Wisconsin – sequence: 5 givenname: Matthew surname: Bosler fullname: Bosler, Matthew organization: Department of Surgery, Division of General Surgery, Medical College of Wisconsin – sequence: 6 givenname: James surname: Wallace fullname: Wallace, James organization: Department of Surgery, Division of General Surgery, Medical College of Wisconsin – sequence: 7 givenname: Jon surname: Gould fullname: Gould, Jon email: jgould@mcw.edu organization: Department of Surgery, Division of General Surgery, Medical College of Wisconsin |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24310740$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1v1DAQhi1URLeFH8AFWeLCJTATO3HCBaGKL6mIC5yjiTPZdZWNF9sR7L_HYQtClYCLLc0873y9F-Js9jML8RjhOQKYFxFA17oAVIVSOj_3xAa1KouyxOZMbKBVUJSm1efiIsYbyHiL1QNxXmqFYDRsxPiRB2dpmo4y8BjIJh-OcksxBc_RH3a0ZZrW3LR8l4OLTJGlm2XasfQ9R34pv-0oSRd_hnIkybiE7VpU0uEQPNndq4fi_khT5Ee3_6X48vbN56v3xfWndx-uXl8XVkOVilFVfa01VqbvEUYmhAGNrg1XQ95l1GNNNRsgYEWqGYbRWsqEGbCntrHqUjw71c19vy55lm7vouVpopn9EjtsWqMMNk3zf7TCWgOUekWf3kFv_BLmvMhKVaVGNCpTT26ppd_z0B2C21M4dr-OnQE8ATb4GPNJfyMI3WpodzK0y4Z2q6HdWtTc0ViXKDk_p0Bu-qeyPClj7jJvOfwx9F9FPwAZerOd |
CitedBy_id | crossref_primary_10_1016_j_cireng_2023_11_008 crossref_primary_10_1016_j_bpg_2014_07_012 crossref_primary_10_1007_s11894_019_0709_2 crossref_primary_10_1007_s00464_016_4989_4 crossref_primary_10_1111_nyas_13104 crossref_primary_10_1016_j_cgh_2019_08_019 crossref_primary_10_1089_lap_2019_0218 crossref_primary_10_1007_s11695_021_05465_z crossref_primary_10_1080_17474124_2016_1179576 crossref_primary_10_1089_bari_2018_0018 crossref_primary_10_1016_j_ciresp_2023_02_004 crossref_primary_10_1007_s11605_014_2656_4 crossref_primary_10_1007_s11695_022_06401_5 crossref_primary_10_1016_j_surg_2015_04_034 crossref_primary_10_1111_apt_15295 crossref_primary_10_1007_s11695_014_1470_0 crossref_primary_10_1007_s00464_019_07231_w crossref_primary_10_1007_s11894_017_0582_9 crossref_primary_10_1007_s12262_021_02774_6 crossref_primary_10_1080_00015458_2015_11681110 crossref_primary_10_1590_s0004_2803_201800000_39 crossref_primary_10_1016_j_tgie_2015_02_009 crossref_primary_10_1089_bari_2021_0122 |
Cites_doi | 10.1001/jama.2012.39 10.1007/s11605-009-0837-3 10.1007/s00464-007-9490-7 10.1053/j.gastro.2005.12.016 10.1001/archsurg.141.3.247 10.1007/s11695-008-9474-2 10.1097/MEG.0b013e328332f7b8 10.1097/00000441-200311000-00002 10.7326/0003-4819-143-3-200508020-00006 10.1007/s00464-011-1961-1 10.1007/s00464-011-1851-6 10.1016/j.soard.2010.09.011 10.1007/s00464-005-0031-y 10.3748/wjg.v16.i30.3757 10.1007/s00464-003-8118-9 10.1381/096089298765555024 10.1016/j.soard.2008.08.021 10.1097/SLA.0b013e3181bdff20 10.1016/j.soard.2010.08.012 10.1007/s00464-001-8313-5 10.1016/j.thorsurg.2011.08.004 10.1001/jama.292.14.1724 10.1016/S0039-6109(05)70184-5 10.1007/s00464-001-9225-0 10.1007/s00464-010-1487-y 10.1007/s004640090119 10.1016/j.athoracsur.2011.02.088 10.1007/s004640000392 10.1007/s11894-011-0191-y 10.1111/j.1572-0241.2005.41703.x 10.3310/hta17220 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media New York 2013 Springer Science+Business Media New York 2014 |
Copyright_xml | – notice: Springer Science+Business Media New York 2013 – notice: Springer Science+Business Media New York 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7TS |
DOI | 10.1007/s00464-013-3343-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Physical Education Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Physical Education Index |
DatabaseTitleList | Physical Education Index MEDLINE - Academic MEDLINE ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-2218 |
EndPage | 1504 |
ExternalDocumentID | 3272942341 24310740 10_1007_s00464_013_3343_3 |
Genre | Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 123 199 1N0 1SB 203 28- 29Q 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 6PF 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAQQT AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFJLC AFKRA AFLOW AFQWF AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG EX3 F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK8 WOW YLTOR Z45 Z7U Z7X Z82 Z83 Z87 Z88 Z8O Z8R Z8V Z8W Z91 Z92 ZMTXR ZOVNA ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 7TS |
ID | FETCH-LOGICAL-c405t-f35b644157bb10fea10d17467e5d930f4f6a6e70a0e3a38ddfccad177d1ba98c3 |
IEDL.DBID | 7X7 |
ISSN | 0930-2794 1432-2218 |
IngestDate | Thu Sep 04 18:17:41 EDT 2025 Thu Sep 04 22:03:20 EDT 2025 Fri Jul 25 03:24:22 EDT 2025 Mon Jul 21 06:05:51 EDT 2025 Thu Apr 24 23:05:12 EDT 2025 Tue Jul 01 00:24:34 EDT 2025 Fri Feb 21 02:35:38 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Fundoplication GERD Survey Morbid obesity Gastric bypass |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c405t-f35b644157bb10fea10d17467e5d930f4f6a6e70a0e3a38ddfccad177d1ba98c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 24310740 |
PQID | 1515241173 |
PQPubID | 31812 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1897371888 proquest_miscellaneous_1516400248 proquest_journals_1515241173 pubmed_primary_24310740 crossref_primary_10_1007_s00464_013_3343_3 crossref_citationtrail_10_1007_s00464_013_3343_3 springer_journals_10_1007_s00464_013_3343_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-05-01 |
PublicationDateYYYYMMDD | 2014-05-01 |
PublicationDate_xml | – month: 05 year: 2014 text: 2014-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Boston |
PublicationPlace_xml | – name: Boston – name: Germany – name: New York |
PublicationSubtitle | And Other Interventional Techniques Official Journal of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and European Association for Endoscopic Surgery (EAES) |
PublicationTitle | Surgical endoscopy |
PublicationTitleAbbrev | Surg Endosc |
PublicationTitleAlternate | Surg Endosc |
PublicationYear | 2014 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Ibele, Garren, Gould (CR29) 2012; 26 Chisholm, Jamieson, Lally, Devitt, Game, Watson (CR14) 2009; 13 Al Harakeh, Burkhamer, Kallies, Mathiason, Kothari (CR28) 2010; 6 Mejía-Rivas, Herrera-López, Hernández-Calleros, Herrera, Valdovinos (CR4) 2008; 18 Sugerman (CR18) 2001; 81 Vivek, Prachand, Alverdy (CR31) 2010; 16 Frezza, Ikrasmuddin, Gourash, Rakitt, Kingston, Luketich, Schauer (CR9) 2002; 16 Pandolfino, El-Serag, Zhang, Shah, Ghosh, Kahrilas (CR17) 2006; 130 Flegal, Carroll, Kit, Ogden (CR1) 2012; 307 Iovino, Angrisani, Tremolaterra, Nirchio, Ciannella, Borrelli, Sabbatini, Mazzacca, Ciacci (CR24) 2002; 16 Shaheen, Provenzale (CR5) 2003; 326 Chiu, Birch, Shi, Sharma, Karmali (CR23) 2011; 7 Musunuru, Gould (CR16) 2012; 26 Morgenthal, Lin, Shane, Hunter, Smith (CR8) 2007; 21 Madalosso, Gurski, Callegari-Jacques, Navarini, Thiesen, Fornari (CR3) 2010; 251 Jones (CR21) 1998; 8 Grant, Boachie, Cotton, Faria, Bojke, Epstein, Ramsay, Corbacho, Sculpher, Krukowski, Heading, Campbell (CR6) 2013; 17 Tutuian (CR22) 2011; 13 Reavis (CR30) 2011; 21 Winslow, Frisella, Soper, Klingensmith (CR13) 2003; 17 Perez, Moncure, Rattner (CR10) 2001; 15 Fornari, Madalosso, Farré, Gurski, Thiesen, Callegari-Jacquese (CR19) 2010; 22 Varela, Hinojosa, Nguyen (CR27) 2009; 5 Awais, Luketich, Schuchert, Morse, Wilson, Gooding, Landreneau, Pennathur (CR15) 2011; 92 Gould, Ellsmere, Fanelli, Hutter, Jones, Pratt, Schauer, Schirmer, Schwaitzberg, Jones (CR32) 2011; 25 Colquitt, Picot, Loveman, Clegg (CR7) 2009; 15 Anvari, Bamehriz (CR12) 2006; 20 Hampel, Abraham, El-Serag (CR2) 2005; 143 El-Serag, Graham, Satia, Rabeneck (CR20) 2005; 100 Hahnloser, Schumacher, Calvin, Cosendey, Petropoulos (CR11) 2002; 16 Klaus, Gruber, Wetscher, Nehoda, Aigner, Peer, Margreiter, Weiss (CR25) 2006; 141 Buchwald, Avidor, Braunwald, Jensen, Pories, Fahrbach, Schoelles (CR26) 2004; 292 C Morgenthal (3343_CR8) 2007; 21 CA Madalosso (3343_CR3) 2010; 251 KB Jones (3343_CR21) 1998; 8 S Musunuru (3343_CR16) 2012; 26 N Shaheen (3343_CR5) 2003; 326 AR Perez (3343_CR10) 2001; 15 H Hampel (3343_CR2) 2005; 143 MA Mejía-Rivas (3343_CR4) 2008; 18 HB El-Serag (3343_CR20) 2005; 100 JA Chisholm (3343_CR14) 2009; 13 HJ Sugerman (3343_CR18) 2001; 81 JE Varela (3343_CR27) 2009; 5 M Anvari (3343_CR12) 2006; 20 A Ibele (3343_CR29) 2012; 26 D Hahnloser (3343_CR11) 2002; 16 KM Reavis (3343_CR30) 2011; 21 ER Winslow (3343_CR13) 2003; 17 AM Grant (3343_CR6) 2013; 17 JE Pandolfino (3343_CR17) 2006; 130 A Klaus (3343_CR25) 2006; 141 S Chiu (3343_CR23) 2011; 7 JL Colquitt (3343_CR7) 2009; 15 H Buchwald (3343_CR26) 2004; 292 P Iovino (3343_CR24) 2002; 16 F Fornari (3343_CR19) 2010; 22 R Tutuian (3343_CR22) 2011; 13 J Gould (3343_CR32) 2011; 25 AB Al Harakeh (3343_CR28) 2010; 6 N Vivek (3343_CR31) 2010; 16 O Awais (3343_CR15) 2011; 92 KM Flegal (3343_CR1) 2012; 307 EE Frezza (3343_CR9) 2002; 16 15929752 - Am J Gastroenterol. 2005 Jun;100(6):1243-50 19370590 - Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003641 19259752 - J Gastrointest Surg. 2009 Jun;13(6):1064-70 16549689 - Arch Surg. 2006 Mar;141(3):247-51 21802068 - Ann Thorac Surg. 2011 Sep;92(3):1083-9; discussion 1089-90 22052421 - Surg Endosc. 2012 Mar;26(3):838-42 9562484 - Obes Surg. 1998 Feb;8(1):35-8 12073000 - Surg Endosc. 2002 Nov;16(11):1631-5 21858578 - Surg Endosc. 2012 Jan;26(1):177-81 16341568 - Surg Endosc. 2006 Feb;20(2):230-4 20698037 - World J Gastroenterol. 2010 Aug 14;16(30):3757-61 21130052 - Surg Obes Relat Dis. 2011 Jul-Aug;7(4):510-5 20110819 - Eur J Gastroenterol Hepatol. 2010 Apr;22(4):404-11 14577029 - Surg Endosc. 2003 Dec;17(12):2003-11 20010088 - Ann Surg. 2010 Feb;251(2):244-8 18996768 - Surg Obes Relat Dis. 2009 Mar-Apr;5(2):139-43 17623236 - Surg Endosc. 2007 Nov;21(11):1978-84 22040631 - Thorac Surg Clin. 2011 Nov;21(4):489-98 15479938 - JAMA. 2004 Oct 13;292(14):1724-37 22253363 - JAMA. 2012 Feb 1;307(5):491-7 21424733 - Curr Gastroenterol Rep. 2011 Jun;13(3):205-12 11443428 - Surg Endosc. 2001 Sep;15(9):986-9 11984683 - Surg Endosc. 2002 Jul;16(7):1027-31 11961603 - Surg Endosc. 2002 Jan;16(1):43-7 16530504 - Gastroenterology. 2006 Mar;130(3):639-49 14615667 - Am J Med Sci. 2003 Nov;326(5):264-73 21111379 - Surg Obes Relat Dis. 2010 Nov-Dec;6(6):591-6 21136099 - Surg Endosc. 2011 Jun;25(6):1730-40 23742987 - Health Technol Assess. 2013 Jun;17 (22):1-167 18512110 - Obes Surg. 2008 Oct;18(10):1217-24 11589245 - Surg Clin North Am. 2001 Oct;81(5):1063-75, vi 16061918 - Ann Intern Med. 2005 Aug 2;143(3):199-211 |
References_xml | – volume: 307 start-page: 491 issue: 5 year: 2012 end-page: 497 ident: CR1 article-title: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010 publication-title: JAMA doi: 10.1001/jama.2012.39 – volume: 13 start-page: 1064 issue: 6 year: 2009 end-page: 1070 ident: CR14 article-title: The effect of obesity on the outcome of laparoscopic antireflux surgery publication-title: J Gastrointest Surg doi: 10.1007/s11605-009-0837-3 – volume: 21 start-page: 1978 issue: 11 year: 2007 end-page: 1984 ident: CR8 article-title: Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes publication-title: Surg Endosc doi: 10.1007/s00464-007-9490-7 – volume: 130 start-page: 639 year: 2006 end-page: 649 ident: CR17 article-title: Obesity: a challenge to esophagogastric junction integrity publication-title: Gastroenterol doi: 10.1053/j.gastro.2005.12.016 – volume: 17 start-page: 1 issue: 22 year: 2013 end-page: 167 ident: CR6 article-title: Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial) publication-title: Health Technol Assess – volume: 141 start-page: 247 year: 2006 end-page: 251 ident: CR25 article-title: Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding publication-title: Arch Surg doi: 10.1001/archsurg.141.3.247 – volume: 18 start-page: 1217 issue: 10 year: 2008 end-page: 1224 ident: CR4 article-title: Gastroesophageal reflux disease in morbid obesity: the effect of Roux-en-Y gastric bypass publication-title: Obes Surg doi: 10.1007/s11695-008-9474-2 – volume: 22 start-page: 404 year: 2010 end-page: 411 ident: CR19 article-title: The role of gastro-oesophageal pressure gradient and sliding hiatal hernia on pathological gastro-oesophageal reflux in severely obese patients publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0b013e328332f7b8 – volume: 326 start-page: 264 year: 2003 end-page: 273 ident: CR5 article-title: The epidemiology of gastroesophageal reflux disease publication-title: Am J Med Sci doi: 10.1097/00000441-200311000-00002 – volume: 143 start-page: 199 issue: 3 year: 2005 end-page: 211 ident: CR2 article-title: Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications publication-title: Ann Intern Med doi: 10.7326/0003-4819-143-3-200508020-00006 – volume: 26 start-page: 838 year: 2012 end-page: 842 ident: CR16 article-title: Perioperative outcomes of surgical procedures for symptomatic fundoplication failure: a retrospective case-control study publication-title: Surg Endosc doi: 10.1007/s00464-011-1961-1 – volume: 26 start-page: 177 issue: 1 year: 2012 end-page: 181 ident: CR29 article-title: The impact of previous fundoplication on laparoscopic gastric bypass outcomes: a case-control evaluation publication-title: Surg Endosc doi: 10.1007/s00464-011-1851-6 – volume: 7 start-page: 510 issue: 4 year: 2011 end-page: 515 ident: CR23 article-title: Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2010.09.011 – volume: 20 start-page: 230 issue: 2 year: 2006 end-page: 234 ident: CR12 article-title: Outcome of laparoscopic Nissen fundoplication in patients with body mass index ≥35 publication-title: Surg Endosc doi: 10.1007/s00464-005-0031-y – volume: 16 start-page: 3757 issue: 30 year: 2010 end-page: 3761 ident: CR31 article-title: Gastroesophageal reflux disease and severe obesity: fundoplication or bariatric surgery? publication-title: World J Gastroenterol doi: 10.3748/wjg.v16.i30.3757 – volume: 17 start-page: 2003 year: 2003 end-page: 2011 ident: CR13 article-title: Obesity does not adversely affect the outcome of laparoscopic antireflux surgery (LARS) publication-title: Surg Endosc doi: 10.1007/s00464-003-8118-9 – volume: 8 start-page: 35 year: 1998 end-page: 38 ident: CR21 article-title: Roux-en-Y gastric bypass: an effective antireflux procedure in the less than morbidly obese publication-title: Obes Surg doi: 10.1381/096089298765555024 – volume: 5 start-page: 139 year: 2009 end-page: 143 ident: CR27 article-title: Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2008.08.021 – volume: 251 start-page: 244 issue: 2 year: 2010 end-page: 248 ident: CR3 article-title: The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus publication-title: Ann Surg doi: 10.1097/SLA.0b013e3181bdff20 – volume: 6 start-page: 591 issue: 6 year: 2010 end-page: 596 ident: CR28 article-title: Natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2010.08.012 – volume: 16 start-page: 1027 year: 2002 end-page: 1031 ident: CR9 article-title: Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass publication-title: Surg Endosc doi: 10.1007/s00464-001-8313-5 – volume: 15 start-page: CD003641 issue: 2 year: 2009 ident: CR7 article-title: Surgery for obesity publication-title: Cochrane Database Syst Rev – volume: 21 start-page: 489 issue: 4 year: 2011 end-page: 498 ident: CR30 article-title: Management of the obese patient with gastroesophageal reflux disease publication-title: Thorac Surg Clin doi: 10.1016/j.thorsurg.2011.08.004 – volume: 292 start-page: 1724 issue: 14 year: 2004 end-page: 1737 ident: CR26 article-title: Bariatric surgery: a systematic review and meta-analysis publication-title: JAMA doi: 10.1001/jama.292.14.1724 – volume: 81 start-page: 1063 issue: 5 year: 2001 end-page: 2001 ident: CR18 article-title: Effects of increased intra-abdominal pressure in severe obesity publication-title: Surg Clin North Am doi: 10.1016/S0039-6109(05)70184-5 – volume: 16 start-page: 1631 year: 2002 end-page: 1635 ident: CR24 article-title: Abnormal esophageal acid exposure is common in morbidly obese patients and improves after a successful Lap-band system implantation publication-title: Surg Endosc doi: 10.1007/s00464-001-9225-0 – volume: 25 start-page: 1730 issue: 6 year: 2011 end-page: 1740 ident: CR32 article-title: Panel report: best practices for the surgical treatment of obesity publication-title: Surg Endosc doi: 10.1007/s00464-010-1487-y – volume: 16 start-page: 43 year: 2002 end-page: 47 ident: CR11 article-title: Risk factors for complications of laparoscopic Nissen fundoplication publication-title: Surg Endosc doi: 10.1007/s004640090119 – volume: 92 start-page: 1083 issue: 3 year: 2011 end-page: 1089 ident: CR15 article-title: Reoperative antireflux surgery for failed fundoplication: an analysis of outcomes in 275 patients publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2011.02.088 – volume: 15 start-page: 986 year: 2001 end-page: 989 ident: CR10 article-title: Obesity adversely affects the outcome of antireflux operations publication-title: Surg Endosc doi: 10.1007/s004640000392 – volume: 13 start-page: 205 issue: 3 year: 2011 end-page: 212 ident: CR22 article-title: Obesity and GERD: pathophysiology and effect of bariatric surgery publication-title: Curr Gastroenterol Rep doi: 10.1007/s11894-011-0191-y – volume: 100 start-page: 1243 year: 2005 end-page: 1250 ident: CR20 article-title: Obesity is an independent risk factor for GERD symptoms and erosive esophagitis publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2005.41703.x – volume: 6 start-page: 591 issue: 6 year: 2010 ident: 3343_CR28 publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2010.08.012 – volume: 16 start-page: 1631 year: 2002 ident: 3343_CR24 publication-title: Surg Endosc doi: 10.1007/s00464-001-9225-0 – volume: 20 start-page: 230 issue: 2 year: 2006 ident: 3343_CR12 publication-title: Surg Endosc doi: 10.1007/s00464-005-0031-y – volume: 13 start-page: 1064 issue: 6 year: 2009 ident: 3343_CR14 publication-title: J Gastrointest Surg doi: 10.1007/s11605-009-0837-3 – volume: 18 start-page: 1217 issue: 10 year: 2008 ident: 3343_CR4 publication-title: Obes Surg doi: 10.1007/s11695-008-9474-2 – volume: 81 start-page: 1063 issue: 5 year: 2001 ident: 3343_CR18 publication-title: Surg Clin North Am doi: 10.1016/S0039-6109(05)70184-5 – volume: 17 start-page: 1 issue: 22 year: 2013 ident: 3343_CR6 publication-title: Health Technol Assess doi: 10.3310/hta17220 – volume: 16 start-page: 43 year: 2002 ident: 3343_CR11 publication-title: Surg Endosc doi: 10.1007/s004640090119 – volume: 292 start-page: 1724 issue: 14 year: 2004 ident: 3343_CR26 publication-title: JAMA doi: 10.1001/jama.292.14.1724 – volume: 15 start-page: CD003641 issue: 2 year: 2009 ident: 3343_CR7 publication-title: Cochrane Database Syst Rev – volume: 5 start-page: 139 year: 2009 ident: 3343_CR27 publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2008.08.021 – volume: 130 start-page: 639 year: 2006 ident: 3343_CR17 publication-title: Gastroenterol doi: 10.1053/j.gastro.2005.12.016 – volume: 326 start-page: 264 year: 2003 ident: 3343_CR5 publication-title: Am J Med Sci doi: 10.1097/00000441-200311000-00002 – volume: 15 start-page: 986 year: 2001 ident: 3343_CR10 publication-title: Surg Endosc doi: 10.1007/s004640000392 – volume: 8 start-page: 35 year: 1998 ident: 3343_CR21 publication-title: Obes Surg doi: 10.1381/096089298765555024 – volume: 17 start-page: 2003 year: 2003 ident: 3343_CR13 publication-title: Surg Endosc doi: 10.1007/s00464-003-8118-9 – volume: 307 start-page: 491 issue: 5 year: 2012 ident: 3343_CR1 publication-title: JAMA doi: 10.1001/jama.2012.39 – volume: 22 start-page: 404 year: 2010 ident: 3343_CR19 publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0b013e328332f7b8 – volume: 26 start-page: 177 issue: 1 year: 2012 ident: 3343_CR29 publication-title: Surg Endosc doi: 10.1007/s00464-011-1851-6 – volume: 251 start-page: 244 issue: 2 year: 2010 ident: 3343_CR3 publication-title: Ann Surg doi: 10.1097/SLA.0b013e3181bdff20 – volume: 21 start-page: 1978 issue: 11 year: 2007 ident: 3343_CR8 publication-title: Surg Endosc doi: 10.1007/s00464-007-9490-7 – volume: 7 start-page: 510 issue: 4 year: 2011 ident: 3343_CR23 publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2010.09.011 – volume: 16 start-page: 1027 year: 2002 ident: 3343_CR9 publication-title: Surg Endosc doi: 10.1007/s00464-001-8313-5 – volume: 26 start-page: 838 year: 2012 ident: 3343_CR16 publication-title: Surg Endosc doi: 10.1007/s00464-011-1961-1 – volume: 25 start-page: 1730 issue: 6 year: 2011 ident: 3343_CR32 publication-title: Surg Endosc doi: 10.1007/s00464-010-1487-y – volume: 100 start-page: 1243 year: 2005 ident: 3343_CR20 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2005.41703.x – volume: 141 start-page: 247 year: 2006 ident: 3343_CR25 publication-title: Arch Surg doi: 10.1001/archsurg.141.3.247 – volume: 143 start-page: 199 issue: 3 year: 2005 ident: 3343_CR2 publication-title: Ann Intern Med doi: 10.7326/0003-4819-143-3-200508020-00006 – volume: 13 start-page: 205 issue: 3 year: 2011 ident: 3343_CR22 publication-title: Curr Gastroenterol Rep doi: 10.1007/s11894-011-0191-y – volume: 21 start-page: 489 issue: 4 year: 2011 ident: 3343_CR30 publication-title: Thorac Surg Clin doi: 10.1016/j.thorsurg.2011.08.004 – volume: 92 start-page: 1083 issue: 3 year: 2011 ident: 3343_CR15 publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2011.02.088 – volume: 16 start-page: 3757 issue: 30 year: 2010 ident: 3343_CR31 publication-title: World J Gastroenterol doi: 10.3748/wjg.v16.i30.3757 – reference: 18996768 - Surg Obes Relat Dis. 2009 Mar-Apr;5(2):139-43 – reference: 17623236 - Surg Endosc. 2007 Nov;21(11):1978-84 – reference: 22040631 - Thorac Surg Clin. 2011 Nov;21(4):489-98 – reference: 19370590 - Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003641 – reference: 16341568 - Surg Endosc. 2006 Feb;20(2):230-4 – reference: 21858578 - Surg Endosc. 2012 Jan;26(1):177-81 – reference: 22052421 - Surg Endosc. 2012 Mar;26(3):838-42 – reference: 9562484 - Obes Surg. 1998 Feb;8(1):35-8 – reference: 20110819 - Eur J Gastroenterol Hepatol. 2010 Apr;22(4):404-11 – reference: 11961603 - Surg Endosc. 2002 Jan;16(1):43-7 – reference: 15479938 - JAMA. 2004 Oct 13;292(14):1724-37 – reference: 14577029 - Surg Endosc. 2003 Dec;17(12):2003-11 – reference: 21111379 - Surg Obes Relat Dis. 2010 Nov-Dec;6(6):591-6 – reference: 18512110 - Obes Surg. 2008 Oct;18(10):1217-24 – reference: 11984683 - Surg Endosc. 2002 Jul;16(7):1027-31 – reference: 16549689 - Arch Surg. 2006 Mar;141(3):247-51 – reference: 23742987 - Health Technol Assess. 2013 Jun;17 (22):1-167 – reference: 14615667 - Am J Med Sci. 2003 Nov;326(5):264-73 – reference: 11589245 - Surg Clin North Am. 2001 Oct;81(5):1063-75, vi – reference: 22253363 - JAMA. 2012 Feb 1;307(5):491-7 – reference: 21136099 - Surg Endosc. 2011 Jun;25(6):1730-40 – reference: 19259752 - J Gastrointest Surg. 2009 Jun;13(6):1064-70 – reference: 11443428 - Surg Endosc. 2001 Sep;15(9):986-9 – reference: 21802068 - Ann Thorac Surg. 2011 Sep;92(3):1083-9; discussion 1089-90 – reference: 16061918 - Ann Intern Med. 2005 Aug 2;143(3):199-211 – reference: 20698037 - World J Gastroenterol. 2010 Aug 14;16(30):3757-61 – reference: 15929752 - Am J Gastroenterol. 2005 Jun;100(6):1243-50 – reference: 12073000 - Surg Endosc. 2002 Nov;16(11):1631-5 – reference: 16530504 - Gastroenterology. 2006 Mar;130(3):639-49 – reference: 21424733 - Curr Gastroenterol Rep. 2011 Jun;13(3):205-12 – reference: 21130052 - Surg Obes Relat Dis. 2011 Jul-Aug;7(4):510-5 – reference: 20010088 - Ann Surg. 2010 Feb;251(2):244-8 |
SSID | ssj0004915 |
Score | 2.2164788 |
Snippet | Background
Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be... Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be appropriate in the... Background: Obesity is a recognized risk factor for gastroesophageal reflux disease (GERD). Traditional antireflux surgery (fundoplication) may not be... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1500 |
SubjectTerms | Abdominal Surgery Adult Body Mass Index Clinical Competence Comorbidity Decision Making Drug Resistance Endoscopy Female Fundoplication - methods Gastric Bypass - methods Gastroenterology Gastroesophageal reflux Gastroesophageal Reflux - complications Gastroesophageal Reflux - drug therapy Gastroesophageal Reflux - surgery Gastrointestinal surgery Gynecology Hepatology Humans Laparoscopy Laparoscopy - methods Male Medicine Medicine & Public Health Middle Aged Obesity Obesity, Morbid - complications Obesity, Morbid - surgery Patients Proctology Proton Pump Inhibitors - therapeutic use Retrospective Studies Risk Factors Surgeons Surgery Surveys and Questionnaires Third party Treatment Outcome Weight control |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8QwEA66gngR366uEsGTEmib9OVFFlEWYT25sLeStIkuLK30ge6_d5I-VFYXvPSQTEKYmcx8ZTIzCF3K0AW3wUMCFtIhzIsl4Z7PifbFjPk8jC2d4Dx-8kYT9jh1p00ed9G-dm9DksZSd8luJgpHdDcCShl81tGGq8tJgRJPnOFXMmRYty0IqUUc0LY2lPnbFj-d0RLCXIqOGqfzsIO2G7SIh7V4d9GaTPfQ5riJh-8j1cRZ5gsMm-emd84Cv_CizDOpGxSAtYD1MDevPnATjMGzFAPsw5mQhbzB76-8xLPCDMFIiYsqN-YQt_XGbw_Q5OH--W5Ems4JJAYAVhJFXaGBjusLYVtKcttKbN1YRLoJ8EUx5XFP-ha3JOU0SBIFggQKP7EFD4OYHqJemqXyGOFEqdB3mILfspjZ3BZuEjsAAkTCOdDLPrJaFkZxU1Zcd7eYR11BZMP1CLgeaa5HtI-uuiVvdU2NVcSDVi5Rc72KSKMwgB62D9MX3TRcDB3t4KnMKkPjMVOybQVNEPoUvHMANEe1zLsTOQCtAF9ZfXTdKsG3A_x13JN_UZ-iLQBgrH5AOUC9Mq_kGYCcUpwbpf4EI_TyJg priority: 102 providerName: Springer Nature |
Title | Medically refractory gastroesophageal reflux disease in the obese: what is the best surgical approach? |
URI | https://link.springer.com/article/10.1007/s00464-013-3343-3 https://www.ncbi.nlm.nih.gov/pubmed/24310740 https://www.proquest.com/docview/1515241173 https://www.proquest.com/docview/1516400248 https://www.proquest.com/docview/1897371888 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS-QwEB5OBfHluDt_3HoqOfBJCbZN2mzvRdZjPTlRRFxYn0raJCosrW67qP_9TdJ0vUNuX1pIJiVMkpmvmWQ-gH2dxug2ZErRQkaUJ4WmMhGSWl_MuZBpEdgLzheXydmI_x7HY7_hVvtjlZ1NdIZaVYXdIz-yjhe9TSjY8eMTtaxRNrrqKTSWYCVEJGKpG8RYvN2LTFsGA6yhEU68LqoZtElEE3v-glHGOD7-9UvvwOa7QKnzP6ef4KMHjmTQjvRn-KDLL7B64UPj62B8yGXySvDjU0ej80ruZN1MK225CtBwYHusm8xeiI_LkIeSIAIkVa5r_YM838uGPNSuCEsaUs-mzjKSLvX48QaMToc3P8-oJ1GgBWKxhhoW5xbzxCLPw8BoGQYqtBwjOlaoF8NNIhMtAhloJllfKYNjihJChblM-wXbhOWyKvVXIMqYVETc4B9awUMZ5rEqIsQDuZIS5XUPgk6FWeEzjFuii0k2z43stJ6h1jOr9Yz14GDe5LFNr7FIeKcbl8yvtDp7mxc9-D6vxjViAx-y1NXMySTcZW9bINNPBUNH3UeZrXbM5z2KEGUh1Ap6cNhNgr868L_ubi_u7jdYQ_DF28OTO7DcTGd6FwFOk--5WbwHK4Nft-dDfJ8ML6-usXQUDf4AtOL5ow |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB7RRWq5oD5hgbau1F5aWXViJ9lUQqgP0FLYVVWBxC11YpsirRK6yQr2z_W3dew4SyvUvXHJIZlYzng88zljzwfwWqcRhg2ZUvSQIRVxoamME0ltLBYikWnB7AHn0TgenoqvZ9HZCvzuzsLYbZWdT3SOWlWF_Uf-3gZejDZBwvcuf1HLGmWzqx2FhvTUCmrXlRjzBzuO9PwKl3D17uEXHO83YXiwf_J5SD3LAC0QrDTU8Ci3oCBK8jxgRsuAqcCScOhIpZwZYWIZ64RJprnkA6UMfjRKJCrIZTooOLZ7D1aF_YHSg9VP--Nv329OZqYthwI2REM0_S6vytoyprHdAcIp5wIv_0bGW3D3VqrWRcCDh7DuoSv52NraI1jR5WO4P_LJ-SdgfNJnMifY-NQR-czJuaybaaUtWwK6Lnwfn01m18RnhshFSRCDkirXtf5Arn7KhlzU7hbeaUg9mzrfTLri53tP4fROFPwMemVV6k0gypg0CYXBNWIhAhnkkSpCRCS5khLldR9Yp8Ks8DXOLdXGJFtUZ3Zaz1DrmdV6xvvwdvHKZVvgY5nwTjcumZ_rdXZjmX14tXiMs9SmXmSpq5mTiYWrH7dEZpAmHKHCAGU22jFf9ChEnIdgj_XhXWcEf3Xgf93dWt7dl_BgeDI6zo4Px0fbsIZQULRbOXeg10xn-jnCrSZ_4W2awI-7nkZ_ACZrOjk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VVqq4IL7ZUsBIcAFZdWIn3iBVFdCuWkpXFaJSb6kT21BplbSbrMr-RX4VY8fZgir21ksOzsSyxp6Z54w9D-CNyRIMGyqj6CFjKtLSUJVKRV0sFkKqrGTugvPRON0_EV9Ok9MV-N3fhXHHKnuf6B21rkv3j3zLBV6MNpHkWzYcizjeHe1cXFLHIOUyrT2dhgo0C3rblxsLlzwOzfwKt3PN9sEuzv3bOB7tff-8TwPjAC0RuLTU8qRwACGRRRExa1TEdOQIOUyiM86ssKlKjWSKGa74UGuLCkAJqaNCZcOSY793YE1i1MeN4NqnvfHxt-tbmlnHp4Ad0RjNoM-xsq6kaepOg3DKucDHv1HyBvS9kbb10XB0H-4FGEs-duvuAayY6iGsH4VE_SOwIQE0mRPsfOpJfebkh2raaW0ccwK6Mfwe301mv0jIEpHziiAeJXVhGvOBXP1ULTlvfBO2tKSZTb2fJn0h9J3HcHIrCn4Cq1VdmWdAtLWZjIXF_WIpIhUViS5jRCeFVgrlzQBYr8K8DPXOHe3GJF9UavZaz1HrudN6zgfwbvHJRVfsY5nwZj8vebD7Jr9epQN4vXiNFuvSMKoy9czLpMLXklsiM8wkR9gwRJmn3ZwvRhQj5kPgxwbwvl8Efw3gf8PdWD7cV7CO5pR_PRgfPoe7iApFd6pzE1bb6cy8QOTVFi_DkiZwdttW9AcG0j59 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Medically+refractory+gastroesophageal+reflux+disease+in+the+obese%3A+what+is+the+best+surgical+approach%3F&rft.jtitle=Surgical+endoscopy&rft.au=Page%2C+Maurice-Pierre&rft.au=Kastenmeier%2C+Andrew&rft.au=Goldblatt%2C+Matthew&rft.au=Frelich%2C+Matthew&rft.date=2014-05-01&rft.issn=0930-2794&rft.eissn=1432-2218&rft.volume=28&rft.issue=5&rft.spage=1500&rft.epage=1504&rft_id=info:doi/10.1007%2Fs00464-013-3343-3&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0930-2794&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0930-2794&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0930-2794&client=summon |